<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<References xsi:schemaLocation="http://www.iedb.org/schema/CurationSchema http://beta.iedb.org/schema/Curation.xsd" xmlns="http://www.iedb.org/schema/CurationSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <Reference>
        <ReferenceId>987</ReferenceId>
        <DateLastUpdated>2018-09-17-07:00</DateLastUpdated>
        <Article>
            <PubmedId>15153510</PubmedId>
            <Abstract>Using plasmid vaccination with DNA encoding the putative phosphate transport receptor PstS-3 from Mycobacterium tuberculosis and 36 overlapping 20-mer peptides spanning the entire PstS-3 sequence, we determined the immunodominant Th1-type CD4(+) T cell epitopes in C57BL/10 mice, as measured by spleen cell IL-2 and IFN-gamma production. Furthermore, a potent IFN-gamma-inducing, D(b)-restricted CD8(+) epitope was identified using MHC class I mutant B6.C-H-2(bm13) mice and intracellular IFN-gamma and whole blood CD8(+) T cell tetramer staining. Using adoptive transfer of CFSE-labeled, peptide-pulsed syngeneic spleen cells from naive animals into DNA vaccinated or M. tuberculosis-infected recipients, we demonstrated a functional in vivo CTL activity against this D(b)-restricted PstS-3 epitope. IFN-gamma ELISPOT responses to this epitope were also detected in tuberculosis-infected mice. The CD4(+) and CD8(+) T cell epitopes defined for PstS-3 were completely specific and not recognized in mice vaccinated with either PstS-1 or PstS-2 DNA. The H-2 haplotype exerted a strong influence on immune reactivity to the PstS-3 Ag, and mice of the H-2(b, p, and f) haplotype produced significant Ab and Th1-type cytokine levels, whereas mice of H-2(d, k, r, s, and q) haplotype were completely unreactive. Low responsiveness against PstS-3 in MHC class II mutant B6.C-H-2(bm12) mice could be overcome by DNA vaccination. IFN-gamma-producing CD8(+) T cells could also be detected against the D(b)-restricted epitope in H-2(p) haplotype mice. These results highlight the potential of DNA vaccination for the induction and characterization of CD4(+) and particularly CD8(+) T cell responses against mycobacterial Ags.</Abstract>
            <ArticleYear>2004</ArticleYear>
            <ArticlePages>6913-21</ArticlePages>
            <ArticleTitle>Induction of in vivo functional Db-restricted cytolytic T cell activity against a putative phosphate transport receptor of Mycobacterium tuberculosis.</ArticleTitle>
            <Authors>
                <Author>
                    <LastName>Romano</LastName>
                    <ForeName>Marta</ForeName>
                </Author>
                <Author>
                    <LastName>Denis</LastName>
                    <ForeName>Olivier</ForeName>
                </Author>
                <Author>
                    <LastName>D'Souza</LastName>
                    <ForeName>Sushila</ForeName>
                </Author>
                <Author>
                    <LastName>Wang</LastName>
                    <ForeName>Xiao-Ming</ForeName>
                </Author>
                <Author>
                    <LastName>Ottenhoff</LastName>
                    <ForeName>Tom H M</ForeName>
                </Author>
                <Author>
                    <LastName>Brulet</LastName>
                    <ForeName>Jean-Marc</ForeName>
                </Author>
                <Author>
                    <LastName>Huygen</LastName>
                    <ForeName>Kris</ForeName>
                </Author>
            </Authors>
            <Affiliations>Laboratory of Mycobacterial Immunology, Pasteur Institute of Brussels, Brussels, Belgium.</Affiliations>
            <ArticleChemicalList>ATP-Binding Cassette Transporters;Antibodies, Bacterial;Bacterial Proteins;Epitopes, T-Lymphocyte;H-2 Antigens;Histocompatibility Antigen H-2D;Interleukin-2;PstS-3 protein, Mycobacterium tuberculosis;Tuberculosis Vaccines;Vaccines, DNA;Interferon-gamma</ArticleChemicalList>
            <ArticleMeshHeadingsList>ATP-Binding Cassette Transporters(immunology); Amino Acid Sequence; Animals; Antibodies, Bacterial(blood); Bacterial Proteins(immunology); Epitopes, T-Lymphocyte; H-2 Antigens(physiology); Histocompatibility Antigen H-2D; Interferon-gamma(biosynthesis); Interleukin-2(biosynthesis); Mice; Mice, Inbred C57BL; Molecular Sequence Data; Mycobacterium tuberculosis(immunology); T-Lymphocytes, Cytotoxic(immunology); Th1 Cells(immunology); Tuberculosis Vaccines(immunology); Vaccines, DNA(immunology)</ArticleMeshHeadingsList>
            <Journal>
                <Volume>172</Volume>
                <Issue>11</Issue>
                <Title>Journal of immunology (Baltimore, Md. : 1950)</Title>
                <Issn>0022-1767</Issn>
                <MedlineTa>J Immunol</MedlineTa>
            </Journal>
        </Article>
        <Epitopes>
            <Epitope>
                <EpitopeName>PstS-3 1-20</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>MKLNRFGAAVGVLAAGALVL</LinearSequence>
                        <StartingPosition>1</StartingPosition>
                        <EndingPosition>20</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>CAA88138.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>652616</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table I</LocationOfData>
                <EpitopeId>41860</EpitopeId>
                <ReferenceStartingPosition>1</ReferenceStartingPosition>
                <ReferenceEndingPosition>20</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>Protein is also known as Phosphate-binding protein 3 precursor, PBP-3 and Ag88.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 7B</LocationOfData>
                        <TCellId>15751</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000271</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>CAA88138.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>652616</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Adjuvant>Vaxfectin</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>3 immunizations 3 weeks apart, with 25 micrograms plasmid in each hindleg.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A 2:1 DNA:adjuvant molar ratio was used. The plasmid expressed human tissue plasminogen..</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenReferenceName>PstS-3 1-20</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>MKLNRFGAAVGVLAAGALVL</LinearSequence>
                                        <StartingPosition>1</StartingPosition>
                                        <EndingPosition>20</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>CAA88138.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>652616</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>H-2b and H-2p bearing congenic mice produced similar results.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 1B</LocationOfData>
                        <TCellId>14453</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000047</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>CAA88138.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>652616</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Adjuvant>Vaxfectin</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>3 immunizations 3 weeks apart, with 25 micrograms plasmid in each hindleg.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A 2:1 DNA:adjuvant molar ratio was used. The plasmid expressed human tissue plasminogen..</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenReferenceName>PstS-3 1-20</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>MKLNRFGAAVGVLAAGALVL</LinearSequence>
                                        <StartingPosition>1</StartingPosition>
                                        <EndingPosition>20</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>CAA88138.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>652616</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>Negative results were also seen for IL-2 secretion, implying that a Th1 secretion profile is not induced with this peptide. Similar results were seen in H-2f and H-2p bearing congenic mice.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 7A</LocationOfData>
                        <TCellId>15750</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000273</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>CAA88138.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>652616</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Adjuvant>Vaxfectin</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>3 immunizations 3 weeks apart, with 25 micrograms plasmid in each hindleg.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A 2:1 DNA:adjuvant molar ratio was used. The plasmid expressed human tissue plasminogen..</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenReferenceName>PstS-3 1-20</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>MKLNRFGAAVGVLAAGALVL</LinearSequence>
                                        <StartingPosition>1</StartingPosition>
                                        <EndingPosition>20</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>CAA88138.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>652616</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>H-2f and H-2b bearing congenic mice produced similar results.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>PstS-3 11-30</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>GVLAAGALVLSACGNDDNVT</LinearSequence>
                        <StartingPosition>11</StartingPosition>
                        <EndingPosition>30</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>CAA88138.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>652616</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table I</LocationOfData>
                <EpitopeId>23029</EpitopeId>
                <ReferenceStartingPosition>11</ReferenceStartingPosition>
                <ReferenceEndingPosition>30</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>Protein is also known as Phosphate-binding protein 3 precursor, PBP-3 and Ag88.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 7B</LocationOfData>
                        <TCellId>15754</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000271</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>CAA88138.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>652616</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Adjuvant>Vaxfectin</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>3 immunizations 3 weeks apart, with 25 micrograms plasmid in each hindleg.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A 2:1 DNA:adjuvant molar ratio was used. The plasmid expressed human tissue plasminogen..</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenReferenceName>PstS-3 11-30</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>GVLAAGALVLSACGNDDNVT</LinearSequence>
                                        <StartingPosition>11</StartingPosition>
                                        <EndingPosition>30</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>CAA88138.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>652616</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>H-2b and H-2p bearing congenic mice produced similar results.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 1B</LocationOfData>
                        <TCellId>14457</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000047</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>CAA88138.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>652616</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Adjuvant>Vaxfectin</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>3 immunizations 3 weeks apart, with 25 micrograms plasmid in each hindleg.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A 2:1 DNA:adjuvant molar ratio was used. The plasmid expressed human tissue plasminogen..</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenReferenceName>PstS-3 11-30</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>GVLAAGALVLSACGNDDNVT</LinearSequence>
                                        <StartingPosition>11</StartingPosition>
                                        <EndingPosition>30</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>CAA88138.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>652616</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>Negative results were also seen for IL-2 secretion, implying that a Th1 secretion profile is not induced with this peptide. Similar results were seen in H-2f and H-2p bearing congenic mice.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 7A</LocationOfData>
                        <TCellId>15753</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000273</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>CAA88138.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>652616</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Adjuvant>Vaxfectin</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>3 immunizations 3 weeks apart, with 25 micrograms plasmid in each hindleg.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A 2:1 DNA:adjuvant molar ratio was used. The plasmid expressed human tissue plasminogen..</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenReferenceName>PstS-3 11-30</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>GVLAAGALVLSACGNDDNVT</LinearSequence>
                                        <StartingPosition>11</StartingPosition>
                                        <EndingPosition>30</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>CAA88138.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>652616</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>H-2f and H-2b bearing congenic mice produced similar results.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>PstS-3 21-40</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>SACGNDDNVTGGGATTGQAS</LinearSequence>
                        <StartingPosition>21</StartingPosition>
                        <EndingPosition>40</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>CAA88138.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>652616</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table I</LocationOfData>
                <EpitopeId>56723</EpitopeId>
                <ReferenceStartingPosition>21</ReferenceStartingPosition>
                <ReferenceEndingPosition>40</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>Protein is also known as Phosphate-binding protein 3 precursor, PBP-3 and Ag88.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 1B</LocationOfData>
                        <TCellId>14458</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000047</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>CAA88138.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>652616</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Adjuvant>Vaxfectin</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>3 immunizations 3 weeks apart, with 25 micrograms plasmid in each hindleg.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A 2:1 DNA:adjuvant molar ratio was used. The plasmid expressed human tissue plasminogen..</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenReferenceName>PstS-3 21-40</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>SACGNDDNVTGGGATTGQAS</LinearSequence>
                                        <StartingPosition>21</StartingPosition>
                                        <EndingPosition>40</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>CAA88138.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>652616</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>Negative results were also  een for IL-2 secretion, implying that a Th1 secretion profile is not induced with this peptide. Similar results were seen in H-2f and H-2p bearing congenic mice.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 7A</LocationOfData>
                        <TCellId>15755</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000273</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>CAA88138.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>652616</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Adjuvant>Vaxfectin</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>3 immunizations 3 weeks apart, with 25 micrograms plasmid in each hindleg.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A 2:1 DNA:adjuvant molar ratio was used. The plasmid expressed human tissue plasminogen..</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenReferenceName>PstS-3 21-40</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>SACGNDDNVTGGGATTGQAS</LinearSequence>
                                        <StartingPosition>21</StartingPosition>
                                        <EndingPosition>40</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>CAA88138.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>652616</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>H-2f and H-2b bearing congenic mice produced similar results.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 7B</LocationOfData>
                        <TCellId>15756</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000271</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>CAA88138.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>652616</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Adjuvant>Vaxfectin</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>3 immunizations 3 weeks apart, with 25 micrograms plasmid in each hindleg.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A 2:1 DNA:adjuvant molar ratio was used. The plasmid expressed human tissue plasminogen..</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenReferenceName>PstS-3 21-40</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>SACGNDDNVTGGGATTGQAS</LinearSequence>
                                        <StartingPosition>21</StartingPosition>
                                        <EndingPosition>40</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>CAA88138.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>652616</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>H-2b and H-2p bearing congenic mice produced similar results.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>PstS-3 31-50</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>GGGATTGQASAKVDCGGKKT</LinearSequence>
                        <StartingPosition>31</StartingPosition>
                        <EndingPosition>50</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>CAA88138.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>652616</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table I</LocationOfData>
                <EpitopeId>19739</EpitopeId>
                <ReferenceStartingPosition>31</ReferenceStartingPosition>
                <ReferenceEndingPosition>50</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>Protein is also known as Phosphate-binding protein 3 precursor, PBP-3 and Ag88.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 1B</LocationOfData>
                        <TCellId>14459</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000047</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>CAA88138.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>652616</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Adjuvant>Vaxfectin</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>3 immunizations 3 weeks apart, with 25 micrograms plasmid in each hindleg.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A 2:1 DNA:adjuvant molar ratio was used. The plasmid expressed human tissue plasminogen..</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenReferenceName>PstS-3 31-50</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>GGGATTGQASAKVDCGGKKT</LinearSequence>
                                        <StartingPosition>31</StartingPosition>
                                        <EndingPosition>50</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>CAA88138.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>652616</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>Negative results were also seen for IL-2 secretion, implying that a Th1 secretion profile is not induced with this peptide. Similar results were seen in H-2f and H-2p bearing congenic mice.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 7A</LocationOfData>
                        <TCellId>15757</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000273</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>CAA88138.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>652616</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Adjuvant>Vaxfectin</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>3 immunizations 3 weeks apart, with 25 micrograms plasmid in each hindleg.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A 2:1 DNA:adjuvant molar ratio was used. The plasmid expressed human tissue plasminogen..</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenReferenceName>PstS-3 31-50</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>GGGATTGQASAKVDCGGKKT</LinearSequence>
                                        <StartingPosition>31</StartingPosition>
                                        <EndingPosition>50</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>CAA88138.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>652616</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>H-2f and H-2b bearing congenic mice produced similar results.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 7B</LocationOfData>
                        <TCellId>15758</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000271</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>CAA88138.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>652616</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Adjuvant>Vaxfectin</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>3 immunizations 3 weeks apart, with 25 micrograms plasmid in each hindleg.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A 2:1 DNA:adjuvant molar ratio was used. The plasmid expressed human tissue plasminogen..</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenReferenceName>PstS-3 31-50</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>GGGATTGQASAKVDCGGKKT</LinearSequence>
                                        <StartingPosition>31</StartingPosition>
                                        <EndingPosition>50</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>CAA88138.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>652616</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>H-2b and H-2p bearing congenic mice produced similar results.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>PstS-3 41-60</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>AKVDCGGKKTLKASGSTAQA</LinearSequence>
                        <StartingPosition>41</StartingPosition>
                        <EndingPosition>60</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>CAA88138.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>652616</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table I</LocationOfData>
                <EpitopeId>2310</EpitopeId>
                <ReferenceStartingPosition>41</ReferenceStartingPosition>
                <ReferenceEndingPosition>60</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>Protein is also known as Phosphate-binding protein 3 precursor, PBP-3 and Ag88.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 7A</LocationOfData>
                        <TCellId>15759</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000273</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>CAA88138.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>652616</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Adjuvant>Vaxfectin</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>3 immunizations 3 weeks apart, with 25 micrograms plasmid in each hindleg.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A 2:1 DNA:adjuvant molar ratio was used. The plasmid expressed human tissue plasminogen..</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenReferenceName>PstS-3 41-60</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>AKVDCGGKKTLKASGSTAQA</LinearSequence>
                                        <StartingPosition>41</StartingPosition>
                                        <EndingPosition>60</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>CAA88138.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>652616</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>H-2f and H-2b bearing congenic mice produced similar results.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 7B</LocationOfData>
                        <TCellId>15760</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000271</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>CAA88138.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>652616</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Adjuvant>Vaxfectin</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>3 immunizations 3 weeks apart, with 25 micrograms plasmid in each hindleg.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A 2:1 DNA:adjuvant molar ratio was used. The plasmid expressed human tissue plasminogen..</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenReferenceName>PstS-3 41-60</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>AKVDCGGKKTLKASGSTAQA</LinearSequence>
                                        <StartingPosition>41</StartingPosition>
                                        <EndingPosition>60</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>CAA88138.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>652616</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>H-2b and H-2p bearing congenic mice produced similar results.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 1B</LocationOfData>
                        <TCellId>14460</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000047</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>CAA88138.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>652616</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Adjuvant>Vaxfectin</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>3 immunizations 3 weeks apart, with 25 micrograms plasmid in each hindleg.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A 2:1 DNA:adjuvant molar ratio was used. The plasmid expressed human tissue plasminogen..</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenReferenceName>PstS-3 41-60</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>AKVDCGGKKTLKASGSTAQA</LinearSequence>
                                        <StartingPosition>41</StartingPosition>
                                        <EndingPosition>60</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>CAA88138.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>652616</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>Negative results were also  seen for IL-2 secretion, implying that a Th1 secretion profile is not induced with this peptide. Similar results were seen in H-2f and H-2p bearing congenic mice.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>PstS-3 51-70</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>LKASGSTAQANAMTRFVNVF</LinearSequence>
                        <StartingPosition>51</StartingPosition>
                        <EndingPosition>70</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>CAA88138.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>652616</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table I</LocationOfData>
                <EpitopeId>36806</EpitopeId>
                <ReferenceStartingPosition>51</ReferenceStartingPosition>
                <ReferenceEndingPosition>70</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>Protein is also known as Phosphate-binding protein 3 precursor, PBP-3 and Ag88.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 1B</LocationOfData>
                        <TCellId>14461</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000047</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>CAA88138.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>652616</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Adjuvant>Vaxfectin</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>3 immunizations 3 weeks apart, with 25 micrograms plasmid in each hindleg.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A 2:1 DNA:adjuvant molar ratio was used. The plasmid expressed human tissue plasminogen..</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenReferenceName>PstS-3 51-70</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>LKASGSTAQANAMTRFVNVF</LinearSequence>
                                        <StartingPosition>51</StartingPosition>
                                        <EndingPosition>70</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>CAA88138.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>652616</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>Negative results were also seen for IL-2 secretion, implying that a Th1 secretion profile is not induced with this peptide. Similar results were seen in H-2f and H-2p bearing congenic mice.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 7B</LocationOfData>
                        <TCellId>15762</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000271</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>CAA88138.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>652616</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Adjuvant>Vaxfectin</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>3 immunizations 3 weeks apart, with 25 micrograms plasmid in each hindleg.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A 2:1 DNA:adjuvant molar ratio was used. The plasmid expressed human tissue plasminogen..</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenReferenceName>PstS-3 51-70</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>LKASGSTAQANAMTRFVNVF</LinearSequence>
                                        <StartingPosition>51</StartingPosition>
                                        <EndingPosition>70</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>CAA88138.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>652616</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>H-2b and H-2p bearing congenic mice produced similar results.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 7A</LocationOfData>
                        <TCellId>15761</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000273</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>CAA88138.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>652616</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Adjuvant>Vaxfectin</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>3 immunizations 3 weeks apart, with 25 micrograms plasmid in each hindleg.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A 2:1 DNA:adjuvant molar ratio was used. The plasmid expressed human tissue plasminogen..</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenReferenceName>PstS-3 51-70</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>LKASGSTAQANAMTRFVNVF</LinearSequence>
                                        <StartingPosition>51</StartingPosition>
                                        <EndingPosition>70</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>CAA88138.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>652616</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>H-2f and H-2b bearing congenic mice produced similar results.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>PstS-3 71-90</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>EQACPGQTLNYTANGSGAGI</LinearSequence>
                        <StartingPosition>71</StartingPosition>
                        <EndingPosition>90</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>CAA88138.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>652616</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table I</LocationOfData>
                <EpitopeId>13793</EpitopeId>
                <ReferenceStartingPosition>71</ReferenceStartingPosition>
                <ReferenceEndingPosition>90</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>Protein is also known as Phosphate-binding protein 3 precursor, PBP-3 and Ag88.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 1B</LocationOfData>
                        <TCellId>14463</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000047</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>CAA88138.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>652616</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Adjuvant>Vaxfectin</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>3 immunizations 3 weeks apart, with 25 micrograms plasmid in each hindleg.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A 2:1 DNA:adjuvant molar ratio was used. The plasmid expressed human tissue plasminogen..</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenReferenceName>PstS-3 71-90</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>EQACPGQTLNYTANGSGAGI</LinearSequence>
                                        <StartingPosition>71</StartingPosition>
                                        <EndingPosition>90</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>CAA88138.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>652616</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>Negative results were also seen for IL-2 secretion, implying that a Th1 secretion profile is not induced with this peptide. Similar results were seen in H-2f and H-2p bearing congenic mice.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 7A</LocationOfData>
                        <TCellId>15763</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000273</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>CAA88138.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>652616</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Adjuvant>Vaxfectin</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>3 immunizations 3 weeks apart, with 25 micrograms plasmid in each hindleg.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A 2:1 DNA:adjuvant molar ratio was used. The plasmid expressed human tissue plasminogen..</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenReferenceName>PstS-3 71-90</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>EQACPGQTLNYTANGSGAGI</LinearSequence>
                                        <StartingPosition>71</StartingPosition>
                                        <EndingPosition>90</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>CAA88138.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>652616</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>H-2f and H-2b bearing congenic mice produced similar results.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 7B</LocationOfData>
                        <TCellId>15764</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000047</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>CAA88138.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>652616</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Adjuvant>Vaxfectin</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>3 immunizations 3 weeks apart, with 25 micrograms plasmid in each hindleg.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A 2:1 DNA:adjuvant molar ratio was used. The plasmid expressed human tissue plasminogen..</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenReferenceName>PstS-3 71-90</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>EQACPGQTLNYTANGSGAGI</LinearSequence>
                                        <StartingPosition>71</StartingPosition>
                                        <EndingPosition>90</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>CAA88138.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>652616</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>H-2b and H-2p bearing congenic mice produced similar results.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>PstS-3 81-100</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>YTANGSGAGISEFNGNQTDF</LinearSequence>
                        <StartingPosition>81</StartingPosition>
                        <EndingPosition>100</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>CAA88138.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>652616</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table I</LocationOfData>
                <EpitopeId>75948</EpitopeId>
                <ReferenceStartingPosition>81</ReferenceStartingPosition>
                <ReferenceEndingPosition>100</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>Protein is also known as Phosphate-binding protein 3 precursor, PBP-3 and Ag88.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 7B</LocationOfData>
                        <TCellId>15766</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000271</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>CAA88138.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>652616</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Adjuvant>Vaxfectin</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>3 immunizations 3 weeks apart, with 25 micrograms plasmid in each hindleg.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A 2:1 DNA:adjuvant molar ratio was used. The plasmid expressed human tissue plasminogen..</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenReferenceName>PstS-3 81-100</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>YTANGSGAGISEFNGNQTDF</LinearSequence>
                                        <StartingPosition>81</StartingPosition>
                                        <EndingPosition>100</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>CAA88138.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>652616</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>H-2b and H-2p bearing congenic mice produced similar results.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 7A</LocationOfData>
                        <TCellId>15765</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000273</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>CAA88138.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>652616</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Adjuvant>Vaxfectin</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>3 immunizations 3 weeks apart, with 25 micrograms plasmid in each hindleg.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A 2:1 DNA:adjuvant molar ratio was used. The plasmid expressed human tissue plasminogen..</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenReferenceName>PstS-3 81-100</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>YTANGSGAGISEFNGNQTDF</LinearSequence>
                                        <StartingPosition>81</StartingPosition>
                                        <EndingPosition>100</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>CAA88138.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>652616</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>H-2f and H-2b bearing congenic mice produced similar results.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 1B</LocationOfData>
                        <TCellId>14464</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000047</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>CAA88138.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>652616</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Adjuvant>Vaxfectin</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>3 immunizations 3 weeks apart, with 25 micrograms plasmid in each hindleg.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A 2:1 DNA:adjuvant molar ratio was used. The plasmid expressed human tissue plasminogen..</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenReferenceName>PstS-3 81-100</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>YTANGSGAGISEFNGNQTDF</LinearSequence>
                                        <StartingPosition>81</StartingPosition>
                                        <EndingPosition>100</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>CAA88138.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>652616</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>Negative results were also  seen for IL-2 secretion, implying that a Th1 secretion profile is not induced with this peptide. Similar results were seen in H-2f and H-2p bearing congenic mice.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>PstS-3 91-110</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>SEFNGNQTDFGGSDVPLSKD</LinearSequence>
                        <StartingPosition>91</StartingPosition>
                        <EndingPosition>110</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>CAA88138.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>652616</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table I</LocationOfData>
                <EpitopeId>57430</EpitopeId>
                <ReferenceStartingPosition>91</ReferenceStartingPosition>
                <ReferenceEndingPosition>110</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>Protein is also known as Phosphate-binding protein 3 precursor, PBP-3 and Ag88.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 1B</LocationOfData>
                        <TCellId>14465</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000047</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>CAA88138.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>652616</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Adjuvant>Vaxfectin</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>3 immunizations 3 weeks apart, with 25 micrograms plasmid in each hindleg.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A 2:1 DNA:adjuvant molar ratio was used. The plasmid expressed human tissue plasminogen..</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenReferenceName>PstS-3 91-110</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>SEFNGNQTDFGGSDVPLSKD</LinearSequence>
                                        <StartingPosition>91</StartingPosition>
                                        <EndingPosition>110</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>CAA88138.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>652616</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>Negative results were also  seen for IL-2 secretion, implying that a Th1 secretion profile is not induced with this peptide. Similar results were seen in H-2f and H-2p bearing congenic mice.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 7B</LocationOfData>
                        <TCellId>15768</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000271</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>CAA88138.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>652616</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Adjuvant>Vaxfectin</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>3 immunizations 3 weeks apart, with 25 micrograms plasmid in each hindleg.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A 2:1 DNA:adjuvant molar ratio was used. The plasmid expressed human tissue plasminogen..</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenReferenceName>PstS-3 91-110</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>SEFNGNQTDFGGSDVPLSKD</LinearSequence>
                                        <StartingPosition>91</StartingPosition>
                                        <EndingPosition>110</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>CAA88138.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>652616</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>H-2b and H-2p bearing congenic mice produced similar results.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 7A</LocationOfData>
                        <TCellId>15767</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000273</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>CAA88138.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>652616</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Adjuvant>Vaxfectin</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>3 immunizations 3 weeks apart, with 25 micrograms plasmid in each hindleg.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A 2:1 DNA:adjuvant molar ratio was used. The plasmid expressed human tissue plasminogen..</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenReferenceName>PstS-3 91-110</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>SEFNGNQTDFGGSDVPLSKD</LinearSequence>
                                        <StartingPosition>91</StartingPosition>
                                        <EndingPosition>110</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>CAA88138.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>652616</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>H-2f and H-2b bearing congenic mice produced similar results.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>PstS-3 101-120</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>GGSDVPLSKDEPSGAARCGS</LinearSequence>
                        <StartingPosition>101</StartingPosition>
                        <EndingPosition>120</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>CAA88138.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>652616</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table I</LocationOfData>
                <EpitopeId>20010</EpitopeId>
                <ReferenceStartingPosition>101</ReferenceStartingPosition>
                <ReferenceEndingPosition>120</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>Protein is also known as Phosphate-binding protein 3 precursor, PBP-3 and Ag88.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 1B</LocationOfData>
                        <TCellId>14466</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000047</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>CAA88138.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>652616</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Adjuvant>Vaxfectin</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>3 immunizations 3 weeks apart, with 25 micrograms plasmid in each hindleg.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A 2:1 DNA:adjuvant molar ratio was used. The plasmid expressed human tissue plasminogen..</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenReferenceName>PstS-3 101-120</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>GGSDVPLSKDEPSGAARCGS</LinearSequence>
                                        <StartingPosition>101</StartingPosition>
                                        <EndingPosition>120</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>CAA88138.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>652616</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>Negative results were also  seen for IL-2 secretion, implying that a Th1 secretion profile is not induced with this peptide. Similar results were seen in H-2f and H-2p bearing congenic mice.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 7A</LocationOfData>
                        <TCellId>15769</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000273</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>CAA88138.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>652616</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Adjuvant>Vaxfectin</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>3 immunizations 3 weeks apart, with 25 micrograms plasmid in each hindleg.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A 2:1 DNA:adjuvant molar ratio was used. The plasmid expressed human tissue plasminogen..</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenReferenceName>PstS-3 101-120</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>GGSDVPLSKDEPSGAARCGS</LinearSequence>
                                        <StartingPosition>101</StartingPosition>
                                        <EndingPosition>120</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>CAA88138.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>652616</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>H-2f and H-2b bearing congenic mice produced similar results.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 7B</LocationOfData>
                        <TCellId>15770</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000271</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>CAA88138.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>652616</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Adjuvant>Vaxfectin</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>3 immunizations 3 weeks apart, with 25 micrograms plasmid in each hindleg.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A 2:1 DNA:adjuvant molar ratio was used. The plasmid expressed human tissue plasminogen..</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenReferenceName>PstS-3 101-120</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>GGSDVPLSKDEPSGAARCGS</LinearSequence>
                                        <StartingPosition>101</StartingPosition>
                                        <EndingPosition>120</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>CAA88138.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>652616</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>H-2b and H-2p bearing congenic mice produced similar results.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>PstS-3 111-130</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>EPSGAARCGSPAWNLPVVFG</LinearSequence>
                        <StartingPosition>111</StartingPosition>
                        <EndingPosition>130</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>CAA88138.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>652616</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table I</LocationOfData>
                <EpitopeId>13759</EpitopeId>
                <ReferenceStartingPosition>111</ReferenceStartingPosition>
                <ReferenceEndingPosition>130</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>Protein is also known as Phosphate-binding protein 3 precursor, PBP-3 and Ag88.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 7B</LocationOfData>
                        <TCellId>15773</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000271</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>CAA88138.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>652616</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Adjuvant>Vaxfectin</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>3 immunizations 3 weeks apart, with 25 micrograms plasmid in each hindleg.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A 2:1 DNA:adjuvant molar ratio was used. The plasmid expressed human tissue plasminogen..</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenReferenceName>PstS-3 111-130</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>EPSGAARCGSPAWNLPVVFG</LinearSequence>
                                        <StartingPosition>111</StartingPosition>
                                        <EndingPosition>130</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>CAA88138.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>652616</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>H-2b and H-2p bearing congenic mice produced similar results.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 1B</LocationOfData>
                        <TCellId>14467</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000047</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>CAA88138.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>652616</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Adjuvant>Vaxfectin</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>3 immunizations 3 weeks apart, with 25 micrograms plasmid in each hindleg.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A 2:1 DNA:adjuvant molar ratio was used. The plasmid expressed human tissue plasminogen..</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenReferenceName>PstS-3 111-130</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>EPSGAARCGSPAWNLPVVFG</LinearSequence>
                                        <StartingPosition>111</StartingPosition>
                                        <EndingPosition>130</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>CAA88138.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>652616</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>Negative results were also  seen for IL-2 secretion, implying that a Th1 secretion profile is not induced with this peptide. Similar results were seen in H-2f and H-2p bearing congenic mice.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 7A</LocationOfData>
                        <TCellId>15772</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000273</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>CAA88138.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>652616</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Adjuvant>Vaxfectin</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>3 immunizations 3 weeks apart, with 25 micrograms plasmid in each hindleg.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A 2:1 DNA:adjuvant molar ratio was used. The plasmid expressed human tissue plasminogen..</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenReferenceName>PstS-3 111-130</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>EPSGAARCGSPAWNLPVVFG</LinearSequence>
                                        <StartingPosition>111</StartingPosition>
                                        <EndingPosition>130</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>CAA88138.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>652616</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>H-2f and H-2b bearing congenic mice produced similar results.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>PstS-3 121-140</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>PAWNLPVVFGPIAVTYNLNS</LinearSequence>
                        <StartingPosition>121</StartingPosition>
                        <EndingPosition>140</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>CAA88138.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>652616</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table I</LocationOfData>
                <EpitopeId>47004</EpitopeId>
                <ReferenceStartingPosition>121</ReferenceStartingPosition>
                <ReferenceEndingPosition>140</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>Protein is also known as Phosphate-binding protein 3 precursor, PBP-3 and Ag88.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 7A</LocationOfData>
                        <TCellId>15774</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000273</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>CAA88138.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>652616</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Adjuvant>Vaxfectin</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>3 immunizations 3 weeks apart, with 25 micrograms plasmid in each hindleg.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A 2:1 DNA:adjuvant molar ratio was used. The plasmid expressed human tissue plasminogen..</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenReferenceName>PstS-3 121-140</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>PAWNLPVVFGPIAVTYNLNS</LinearSequence>
                                        <StartingPosition>121</StartingPosition>
                                        <EndingPosition>140</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>CAA88138.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>652616</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>H-2f and H-2b bearing congenic mice produced similar results.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 1B</LocationOfData>
                        <TCellId>14468</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000047</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>CAA88138.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>652616</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Adjuvant>Vaxfectin</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>3 immunizations 3 weeks apart, with 25 micrograms plasmid in each hindleg.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A 2:1 DNA:adjuvant molar ratio was used. The plasmid expressed human tissue plasminogen..</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenReferenceName>PstS-3 121-140</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>PAWNLPVVFGPIAVTYNLNS</LinearSequence>
                                        <StartingPosition>121</StartingPosition>
                                        <EndingPosition>140</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>CAA88138.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>652616</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>Negative results were also  seen for IL-2 secretion, implying that a Th1 secretion profile is not induced with this peptide. Similar results were seen in H-2f and H-2p bearing congenic mice.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 7B</LocationOfData>
                        <TCellId>15775</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000271</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>CAA88138.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>652616</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Adjuvant>Vaxfectin</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>3 immunizations 3 weeks apart, with 25 micrograms plasmid in each hindleg.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A 2:1 DNA:adjuvant molar ratio was used. The plasmid expressed human tissue plasminogen..</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenReferenceName>PstS-3 121-140</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>PAWNLPVVFGPIAVTYNLNS</LinearSequence>
                                        <StartingPosition>121</StartingPosition>
                                        <EndingPosition>140</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>CAA88138.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>652616</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>H-2b and H-2p bearing congenic mice produced similar results.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>PstS-3 141-160</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>VSSLNLDGPTLAKIFNGSIT</LinearSequence>
                        <StartingPosition>141</StartingPosition>
                        <EndingPosition>160</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>CAA88138.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>652616</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table I</LocationOfData>
                <EpitopeId>71127</EpitopeId>
                <ReferenceStartingPosition>141</ReferenceStartingPosition>
                <ReferenceEndingPosition>160</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>Protein is also known as Phosphate-binding protein 3 precursor, PBP-3 and Ag88.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 7B</LocationOfData>
                        <TCellId>15777</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000271</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>CAA88138.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>652616</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Adjuvant>Vaxfectin</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>3 immunizations 3 weeks apart, with 25 micrograms plasmid in each hindleg.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A 2:1 DNA:adjuvant molar ratio was used. The plasmid expressed human tissue plasminogen..</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenReferenceName>PstS-3 141-160</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>VSSLNLDGPTLAKIFNGSIT</LinearSequence>
                                        <StartingPosition>141</StartingPosition>
                                        <EndingPosition>160</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>CAA88138.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>652616</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>H-2b and H-2p bearing congenic mice produced similar results.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 7A</LocationOfData>
                        <TCellId>15776</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000273</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>CAA88138.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>652616</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Adjuvant>Vaxfectin</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>3 immunizations 3 weeks apart, with 25 micrograms plasmid in each hindleg.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A 2:1 DNA:adjuvant molar ratio was used. The plasmid expressed human tissue plasminogen..</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenReferenceName>PstS-3 141-160</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>VSSLNLDGPTLAKIFNGSIT</LinearSequence>
                                        <StartingPosition>141</StartingPosition>
                                        <EndingPosition>160</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>CAA88138.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>652616</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>H-2f and H-2b bearing congenic mice produced similar results.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 1B</LocationOfData>
                        <TCellId>14469</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000047</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>CAA88138.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>652616</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Adjuvant>Vaxfectin</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>3 immunizations 3 weeks apart, with 25 micrograms plasmid in each hindleg.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A 2:1 DNA:adjuvant molar ratio was used. The plasmid expressed human tissue plasminogen..</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenReferenceName>PstS-3 141-160</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>VSSLNLDGPTLAKIFNGSIT</LinearSequence>
                                        <StartingPosition>141</StartingPosition>
                                        <EndingPosition>160</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>CAA88138.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>652616</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>Negative results were also  seen for IL-2 secretion, implying that a Th1 secretion profile is not induced with this peptide. Similar results were seen in H-2f and H-2p bearing congenic mice.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>PstS-3 171-190</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>NRDFTLPGERIHVVFRSDES</LinearSequence>
                        <StartingPosition>171</StartingPosition>
                        <EndingPosition>190</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>CAA88138.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>652616</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table I</LocationOfData>
                <EpitopeId>45658</EpitopeId>
                <ReferenceStartingPosition>171</ReferenceStartingPosition>
                <ReferenceEndingPosition>190</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>Protein is also known as Phosphate-binding protein 3 precursor, PBP-3 and Ag88.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 7A</LocationOfData>
                        <TCellId>15783</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000273</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>CAA88138.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>652616</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Adjuvant>Vaxfectin</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>3 immunizations 3 weeks apart, with 25 micrograms plasmid in each hindleg.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A 2:1 DNA:adjuvant molar ratio was used. The plasmid expressed human tissue plasminogen..</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenReferenceName>PstS-3 171-190</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>NRDFTLPGERIHVVFRSDES</LinearSequence>
                                        <StartingPosition>171</StartingPosition>
                                        <EndingPosition>190</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>CAA88138.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>652616</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>H-2f and H-2b bearing congenic mice produced similar results.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 1B</LocationOfData>
                        <TCellId>14470</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000047</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>CAA88138.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>652616</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Adjuvant>Vaxfectin</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>3 immunizations 3 weeks apart, with 25 micrograms plasmid in each hindleg.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A 2:1 DNA:adjuvant molar ratio was used. The plasmid expressed human tissue plasminogen..</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenReferenceName>PstS-3 171-190</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>NRDFTLPGERIHVVFRSDES</LinearSequence>
                                        <StartingPosition>171</StartingPosition>
                                        <EndingPosition>190</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>CAA88138.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>652616</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>Negative results were also  seen for IL-2 secretion, implying that a Th1 secretion profile is not induced with this peptide. Similar results were seen in H-2f and H-2p bearing congenic mice.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 7B</LocationOfData>
                        <TCellId>15784</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000271</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>CAA88138.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>652616</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Adjuvant>Vaxfectin</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>3 immunizations 3 weeks apart, with 25 micrograms plasmid in each hindleg.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A 2:1 DNA:adjuvant molar ratio was used. The plasmid expressed human tissue plasminogen..</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenReferenceName>PstS-3 171-190</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>NRDFTLPGERIHVVFRSDES</LinearSequence>
                                        <StartingPosition>171</StartingPosition>
                                        <EndingPosition>190</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>CAA88138.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>652616</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>H-2b and H-2p bearing congenic mice produced similar results.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>PstS-3 211-230</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>GAGKSFQGGVGEGARGNDGT</LinearSequence>
                        <StartingPosition>211</StartingPosition>
                        <EndingPosition>230</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>CAA88138.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>652616</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table I</LocationOfData>
                <EpitopeId>18596</EpitopeId>
                <ReferenceStartingPosition>211</ReferenceStartingPosition>
                <ReferenceEndingPosition>230</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>Protein is also known as Phosphate-binding protein 3 precursor, PBP-3 and Ag88.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 7B</LocationOfData>
                        <TCellId>15786</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000271</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>CAA88138.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>652616</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Adjuvant>Vaxfectin</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>3 immunizations 3 weeks apart, with 25 micrograms plasmid in each hindleg.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A 2:1 DNA:adjuvant molar ratio was used. The plasmid expressed human tissue plasminogen..</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenReferenceName>PstS-3 211-230</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>GAGKSFQGGVGEGARGNDGT</LinearSequence>
                                        <StartingPosition>211</StartingPosition>
                                        <EndingPosition>230</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>CAA88138.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>652616</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>H-2b and H-2p bearing congenic mice produced similar results.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 7A</LocationOfData>
                        <TCellId>15785</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000273</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>CAA88138.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>652616</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Adjuvant>Vaxfectin</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>3 immunizations 3 weeks apart, with 25 micrograms plasmid in each hindleg.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A 2:1 DNA:adjuvant molar ratio was used. The plasmid expressed human tissue plasminogen..</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenReferenceName>PstS-3 211-230</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>GAGKSFQGGVGEGARGNDGT</LinearSequence>
                                        <StartingPosition>211</StartingPosition>
                                        <EndingPosition>230</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>CAA88138.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>652616</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>H-2f and H-2b bearing congenic mice produced similar results.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 1B</LocationOfData>
                        <TCellId>14471</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000047</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>CAA88138.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>652616</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Adjuvant>Vaxfectin</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>3 immunizations 3 weeks apart, with 25 micrograms plasmid in each hindleg.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A 2:1 DNA:adjuvant molar ratio was used. The plasmid expressed human tissue plasminogen..</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenReferenceName>PstS-3 211-230</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>GAGKSFQGGVGEGARGNDGT</LinearSequence>
                                        <StartingPosition>211</StartingPosition>
                                        <EndingPosition>230</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>CAA88138.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>652616</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>Negative results were also  seen for IL-2 secretion, implying that a Th1 secretion profile is not induced with this peptide. Similar results were seen in H-2f and H-2p bearing congenic mice.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>PstS-3 221-240</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>GEGARGNDGTSAAAKNTPGS</LinearSequence>
                        <StartingPosition>221</StartingPosition>
                        <EndingPosition>240</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>CAA88138.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>652616</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table I</LocationOfData>
                <EpitopeId>19270</EpitopeId>
                <ReferenceStartingPosition>212</ReferenceStartingPosition>
                <ReferenceEndingPosition>240</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>Protein is also known as Phosphate-binding protein 3 precursor, PBP-3 and Ag88.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>FigFigure</LocationOfData>
                        <TCellId>15787</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000273</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>CAA88138.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>652616</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Adjuvant>Vaxfectin</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>3 immunizations 3 weeks apart, with 25 micrograms plasmid in each hindleg.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A 2:1 DNA:adjuvant molar ratio was used. The plasmid expressed human tissue plasminogen..</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenReferenceName>PstS-3 221-240</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>GEGARGNDGTSAAAKNTPGS</LinearSequence>
                                        <StartingPosition>221</StartingPosition>
                                        <EndingPosition>240</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>CAA88138.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>652616</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>H-2f and H-2b bearing congenic mice produced similar results.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 7B</LocationOfData>
                        <TCellId>15788</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000271</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>CAA88138.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>652616</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Adjuvant>Vaxfectin</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>3 immunizations 3 weeks apart, with 25 micrograms plasmid in each hindleg.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A 2:1 DNA:adjuvant molar ratio was used. The plasmid expressed human tissue plasminogen..</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenReferenceName>PstS-3 221-240</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>GEGARGNDGTSAAAKNTPGS</LinearSequence>
                                        <StartingPosition>221</StartingPosition>
                                        <EndingPosition>240</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>CAA88138.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>652616</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>H-2b and H-2p bearing congenic mice produced similar results.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 1B</LocationOfData>
                        <TCellId>14472</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000047</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>CAA88138.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>652616</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Adjuvant>Vaxfectin</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>3 immunizations 3 weeks apart, with 25 micrograms plasmid in each hindleg.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A 2:1 DNA:adjuvant molar ratio was used. The plasmid expressed human tissue plasminogen..</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenReferenceName>PstS-3 221-240</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>GEGARGNDGTSAAAKNTPGS</LinearSequence>
                                        <StartingPosition>221</StartingPosition>
                                        <EndingPosition>240</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>CAA88138.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>652616</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>Negative results were also  een for IL-2 secretion, implying that a Th1 secretion profile is not induced with this peptide. Similar results were seen in H-2f and H-2p bearing congenic mice.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>PstS-3 231-250</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>SAAAKNTPGSITYNEWSFAQ</LinearSequence>
                        <StartingPosition>231</StartingPosition>
                        <EndingPosition>250</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>CAA88138.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>652616</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table I</LocationOfData>
                <EpitopeId>56690</EpitopeId>
                <ReferenceStartingPosition>231</ReferenceStartingPosition>
                <ReferenceEndingPosition>250</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>Protein is also known as Phosphate-binding protein 3 precursor, PBP-3 and Ag88.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 7A</LocationOfData>
                        <TCellId>15789</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000273</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>CAA88138.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>652616</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Adjuvant>Vaxfectin</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>3 immunizations 3 weeks apart, with 25 micrograms plasmid in each hindleg.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A 2:1 DNA:adjuvant molar ratio was used. The plasmid expressed human tissue plasminogen..</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenReferenceName>PstS-3 231-250</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>SAAAKNTPGSITYNEWSFAQ</LinearSequence>
                                        <StartingPosition>231</StartingPosition>
                                        <EndingPosition>250</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>CAA88138.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>652616</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>H-2f and H-2b bearing congenic mice produced similar results.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 7B</LocationOfData>
                        <TCellId>15790</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000271</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>CAA88138.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>652616</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Adjuvant>Vaxfectin</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>3 immunizations 3 weeks apart, with 25 micrograms plasmid in each hindleg.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A 2:1 DNA:adjuvant molar ratio was used. The plasmid expressed human tissue plasminogen..</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenReferenceName>PstS-3 231-250</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>SAAAKNTPGSITYNEWSFAQ</LinearSequence>
                                        <StartingPosition>231</StartingPosition>
                                        <EndingPosition>250</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>CAA88138.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>652616</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>H-2b and H-2p bearing congenic mice produced similar results.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 1B</LocationOfData>
                        <TCellId>14473</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000047</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>CAA88138.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>652616</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Adjuvant>Vaxfectin</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>3 immunizations 3 weeks apart, with 25 micrograms plasmid in each hindleg.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A 2:1 DNA:adjuvant molar ratio was used. The plasmid expressed human tissue plasminogen..</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenReferenceName>PstS-3 231-250</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>SAAAKNTPGSITYNEWSFAQ</LinearSequence>
                                        <StartingPosition>231</StartingPosition>
                                        <EndingPosition>250</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>CAA88138.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>652616</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>Negative results were also  seen for IL-2 secretion, implying that a Th1 secretion profile is not induced with this peptide. Similar results were seen in H-2f and H-2p bearing congenic mice.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>PstS-3 241-260</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>ITYNEWSFAQAHDLTMANIV</LinearSequence>
                        <StartingPosition>241</StartingPosition>
                        <EndingPosition>260</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>CAA88138.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>652616</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table I</LocationOfData>
                <EpitopeId>29172</EpitopeId>
                <ReferenceStartingPosition>241</ReferenceStartingPosition>
                <ReferenceEndingPosition>260</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>Protein is also known as Phosphate-binding protein 3 precursor, PBP-3 and Ag88.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 7A</LocationOfData>
                        <TCellId>15792</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000273</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>CAA88138.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>652616</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Adjuvant>Vaxfectin</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>3 immunizations 3 weeks apart, with 25 micrograms plasmid in each hindleg.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A 2:1 DNA:adjuvant molar ratio was used. The plasmid expressed human tissue plasminogen..</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenReferenceName>PstS-3 241-260</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>ITYNEWSFAQAHDLTMANIV</LinearSequence>
                                        <StartingPosition>241</StartingPosition>
                                        <EndingPosition>260</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>CAA88138.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>652616</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>H-2f and H-2b bearing congenic mice produced similar results.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 7B</LocationOfData>
                        <TCellId>15793</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000271</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>CAA88138.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>652616</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Adjuvant>Vaxfectin</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>3 immunizations 3 weeks apart, with 25 micrograms plasmid in each hindleg.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A 2:1 DNA:adjuvant molar ratio was used. The plasmid expressed human tissue plasminogen..</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenReferenceName>PstS-3 241-260</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>ITYNEWSFAQAHDLTMANIV</LinearSequence>
                                        <StartingPosition>241</StartingPosition>
                                        <EndingPosition>260</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>CAA88138.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>652616</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>H-2b and H-2p bearing congenic mice produced similar results.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 1B</LocationOfData>
                        <TCellId>14474</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000047</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>CAA88138.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>652616</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Adjuvant>Vaxfectin</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>3 immunizations 3 weeks apart, with 25 micrograms plasmid in each hindleg.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A 2:1 DNA:adjuvant molar ratio was used. The plasmid expressed human tissue plasminogen..</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenReferenceName>PstS-3 241-260</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>ITYNEWSFAQAHDLTMANIV</LinearSequence>
                                        <StartingPosition>241</StartingPosition>
                                        <EndingPosition>260</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>CAA88138.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>652616</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>Negative results were also  seen for IL-2 secretion, implying that a Th1 secretion profile is not induced with this peptide. Similar results were seen in H-2f and H-2p bearing congenic mice.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>PstS-3 251-270</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>AHDLTMANIVTSAGGDPVAI</LinearSequence>
                        <StartingPosition>251</StartingPosition>
                        <EndingPosition>270</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>CAA88138.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>652616</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table I</LocationOfData>
                <EpitopeId>1750</EpitopeId>
                <ReferenceStartingPosition>251</ReferenceStartingPosition>
                <ReferenceEndingPosition>270</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>Protein is also known as Phosphate-binding protein 3 precursor, PBP-3 and Ag88.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 7A</LocationOfData>
                        <TCellId>15794</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000273</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>CAA88138.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>652616</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Adjuvant>Vaxfectin</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>3 immunizations 3 weeks apart, with 25 micrograms plasmid in each hindleg.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A 2:1 DNA:adjuvant molar ratio was used. The plasmid expressed human tissue plasminogen..</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenReferenceName>PstS-3 251-270</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>AHDLTMANIVTSAGGDPVAI</LinearSequence>
                                        <StartingPosition>251</StartingPosition>
                                        <EndingPosition>270</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>CAA88138.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>652616</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>H-2f and H-2b bearing congenic mice produced similar results.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 1B</LocationOfData>
                        <TCellId>14475</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000047</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>CAA88138.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>652616</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Adjuvant>Vaxfectin</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>3 immunizations 3 weeks apart, with 25 micrograms plasmid in each hindleg.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A 2:1 DNA:adjuvant molar ratio was used. The plasmid expressed human tissue plasminogen..</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenReferenceName>PstS-3 251-270</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>AHDLTMANIVTSAGGDPVAI</LinearSequence>
                                        <StartingPosition>251</StartingPosition>
                                        <EndingPosition>270</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>CAA88138.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>652616</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>Negative results were also  seen for IL-2 secretion, implying that a Th1 secretion profile is not induced with this peptide. Similar results were seen in H-2f and H-2p bearing congenic mice.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 7B</LocationOfData>
                        <TCellId>15795</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000271</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>CAA88138.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>652616</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Adjuvant>Vaxfectin</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>3 immunizations 3 weeks apart, with 25 micrograms plasmid in each hindleg.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A 2:1 DNA:adjuvant molar ratio was used. The plasmid expressed human tissue plasminogen..</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenReferenceName>PstS-3 251-270</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>AHDLTMANIVTSAGGDPVAI</LinearSequence>
                                        <StartingPosition>251</StartingPosition>
                                        <EndingPosition>270</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>CAA88138.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>652616</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>H-2b and H-2p bearing congenic mice produced similar results.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>PstS-3 301-320</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>PKRPGSYPIVLATYEIVCSK</LinearSequence>
                        <StartingPosition>301</StartingPosition>
                        <EndingPosition>320</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>CAA88138.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>652616</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table I</LocationOfData>
                <EpitopeId>48133</EpitopeId>
                <ReferenceStartingPosition>301</ReferenceStartingPosition>
                <ReferenceEndingPosition>320</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>Protein is also known as Phosphate-binding protein 3 precursor, PBP-3 and Ag88.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 1B</LocationOfData>
                        <TCellId>14476</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000047</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>CAA88138.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>652616</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Adjuvant>Vaxfectin</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>3 immunizations 3 weeks apart, with 25 micrograms plasmid in each hindleg.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A 2:1 DNA:adjuvant molar ratio was used. The plasmid expressed human tissue plasminogen..</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenReferenceName>PstS-3 301-320</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>PKRPGSYPIVLATYEIVCSK</LinearSequence>
                                        <StartingPosition>301</StartingPosition>
                                        <EndingPosition>320</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>CAA88138.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>652616</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>Negative results were also  seen for IL-2 secretion, implying that a Th1 secretion profile is not induced with this peptide. Similar results were seen in H-2f and H-2p bearing congenic mice.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 7A</LocationOfData>
                        <TCellId>15796</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000273</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>CAA88138.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>652616</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Adjuvant>Vaxfectin</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>3 immunizations 3 weeks apart, with 25 micrograms plasmid in each hindleg.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A 2:1 DNA:adjuvant molar ratio was used. The plasmid expressed human tissue plasminogen..</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenReferenceName>PstS-3 301-320</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>PKRPGSYPIVLATYEIVCSK</LinearSequence>
                                        <StartingPosition>301</StartingPosition>
                                        <EndingPosition>320</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>CAA88138.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>652616</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>H-2f and H-2b bearing congenic mice produced similar results.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 7B</LocationOfData>
                        <TCellId>15797</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000271</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>CAA88138.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>652616</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Adjuvant>Vaxfectin</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>3 immunizations 3 weeks apart, with 25 micrograms plasmid in each hindleg.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A 2:1 DNA:adjuvant molar ratio was used. The plasmid expressed human tissue plasminogen..</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenReferenceName>PstS-3 301-320</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>PKRPGSYPIVLATYEIVCSK</LinearSequence>
                                        <StartingPosition>301</StartingPosition>
                                        <EndingPosition>320</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>CAA88138.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>652616</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>H-2b and H-2p bearing congenic mice produced similar results.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>PstS-3 311-330</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>LATYEIVCSKYPDSQVGTAV</LinearSequence>
                        <StartingPosition>311</StartingPosition>
                        <EndingPosition>330</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>CAA88138.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>652616</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table I</LocationOfData>
                <EpitopeId>34996</EpitopeId>
                <ReferenceStartingPosition>311</ReferenceStartingPosition>
                <ReferenceEndingPosition>330</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>Protein is also known as Phosphate-binding protein 3 precursor, PBP-3 and Ag88.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 7B</LocationOfData>
                        <TCellId>15799</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000271</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>CAA88138.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>652616</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Adjuvant>Vaxfectin</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>3 immunizations 3 weeks apart, with 25 micrograms plasmid in each hindleg.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A 2:1 DNA:adjuvant molar ratio was used. The plasmid expressed human tissue plasminogen..</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenReferenceName>PstS-3 311-330</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>LATYEIVCSKYPDSQVGTAV</LinearSequence>
                                        <StartingPosition>311</StartingPosition>
                                        <EndingPosition>330</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>CAA88138.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>652616</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>H-2b and H-2p bearing congenic mice produced similar results.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 7A</LocationOfData>
                        <TCellId>15798</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000273</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>CAA88138.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>652616</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Adjuvant>Vaxfectin</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>3 immunizations 3 weeks apart, with 25 micrograms plasmid in each hindleg.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A 2:1 DNA:adjuvant molar ratio was used. The plasmid expressed human tissue plasminogen..</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenReferenceName>PstS-3 311-330</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>LATYEIVCSKYPDSQVGTAV</LinearSequence>
                                        <StartingPosition>311</StartingPosition>
                                        <EndingPosition>330</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>CAA88138.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>652616</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>H-2f and H-2b bearing congenic mice produced similar results.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 1B</LocationOfData>
                        <TCellId>14477</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000047</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>CAA88138.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>652616</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Adjuvant>Vaxfectin</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>3 immunizations 3 weeks apart, with 25 micrograms plasmid in each hindleg.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A 2:1 DNA:adjuvant molar ratio was used. The plasmid expressed human tissue plasminogen..</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenReferenceName>PstS-3 311-330</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>LATYEIVCSKYPDSQVGTAV</LinearSequence>
                                        <StartingPosition>311</StartingPosition>
                                        <EndingPosition>330</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>CAA88138.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>652616</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>Negative results were also  seen for IL-2 secretion, implying that a Th1 secretion profile is not induced with this peptide. Similar results were seen in H-2f and H-2p bearing congenic mice.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>PstS-3 321-340</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>YPDSQVGTAVKAFLQSTIGA</LinearSequence>
                        <StartingPosition>321</StartingPosition>
                        <EndingPosition>340</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>CAA88138.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>652616</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table I</LocationOfData>
                <EpitopeId>75271</EpitopeId>
                <ReferenceStartingPosition>321</ReferenceStartingPosition>
                <ReferenceEndingPosition>340</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>Protein is also known as Phosphate-binding protein 3 precursor, PBP-3 and Ag88.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 7B</LocationOfData>
                        <TCellId>15801</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000271</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>CAA88138.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>652616</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Adjuvant>Vaxfectin</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>3 immunizations 3 weeks apart, with 25 micrograms plasmid in each hindleg.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A 2:1 DNA:adjuvant molar ratio was used. The plasmid expressed human tissue plasminogen..</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenReferenceName>PstS-3 321-340</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>YPDSQVGTAVKAFLQSTIGA</LinearSequence>
                                        <StartingPosition>321</StartingPosition>
                                        <EndingPosition>340</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>CAA88138.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>652616</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>H-2b and H-2p bearing congenic mice produced similar results.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 7A</LocationOfData>
                        <TCellId>15800</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000273</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>CAA88138.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>652616</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Adjuvant>Vaxfectin</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>3 immunizations 3 weeks apart, with 25 micrograms plasmid in each hindleg.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A 2:1 DNA:adjuvant molar ratio was used. The plasmid expressed human tissue plasminogen..</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenReferenceName>PstS-3 321-340</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>YPDSQVGTAVKAFLQSTIGA</LinearSequence>
                                        <StartingPosition>321</StartingPosition>
                                        <EndingPosition>340</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>CAA88138.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>652616</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>H-2f and H-2b bearing congenic mice produced similar results.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 1B</LocationOfData>
                        <TCellId>14478</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000047</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>CAA88138.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>652616</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Adjuvant>Vaxfectin</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>3 immunizations 3 weeks apart, with 25 micrograms plasmid in each hindleg.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A 2:1 DNA:adjuvant molar ratio was used. The plasmid expressed human tissue plasminogen..</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenReferenceName>PstS-3 321-340</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>YPDSQVGTAVKAFLQSTIGA</LinearSequence>
                                        <StartingPosition>321</StartingPosition>
                                        <EndingPosition>340</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>CAA88138.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>652616</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>Negative results were also  seen for IL-2 secretion, implying that a Th1 secretion profile is not induced with this peptide. Similar results were seen in H-2f and H-2p bearing congenic mice.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>PstS-3 331-350</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>KAFLQSTIGAGQSGLGDNGY</LinearSequence>
                        <StartingPosition>331</StartingPosition>
                        <EndingPosition>350</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>CAA88138.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>652616</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table I</LocationOfData>
                <EpitopeId>29797</EpitopeId>
                <ReferenceStartingPosition>331</ReferenceStartingPosition>
                <ReferenceEndingPosition>350</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>Protein is also known as Phosphate-binding protein 3 precursor, PBP-3 and Ag88.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 7A</LocationOfData>
                        <TCellId>15802</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000273</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>CAA88138.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>652616</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Adjuvant>Vaxfectin</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>3 immunizations 3 weeks apart, with 25 micrograms plasmid in each hindleg.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A 2:1 DNA:adjuvant molar ratio was used. The plasmid expressed human tissue plasminogen..</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenReferenceName>PstS-3 331-350</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>KAFLQSTIGAGQSGLGDNGY</LinearSequence>
                                        <StartingPosition>331</StartingPosition>
                                        <EndingPosition>350</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>CAA88138.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>652616</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>H-2f and H-2b bearing congenic mice produced similar results.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 1B</LocationOfData>
                        <TCellId>14479</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000047</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>CAA88138.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>652616</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Adjuvant>Vaxfectin</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>3 immunizations 3 weeks apart, with 25 micrograms plasmid in each hindleg.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A 2:1 DNA:adjuvant molar ratio was used. The plasmid expressed human tissue plasminogen..</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenReferenceName>PstS-3 331-350</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>KAFLQSTIGAGQSGLGDNGY</LinearSequence>
                                        <StartingPosition>331</StartingPosition>
                                        <EndingPosition>350</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>CAA88138.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>652616</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>Negative results were also  seen for IL-2 secretion, implying that a Th1 secretion profile is not induced with this peptide. Similar results were seen in H-2f and H-2p bearing congenic mice.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 7B</LocationOfData>
                        <TCellId>15803</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000271</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>CAA88138.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>652616</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Adjuvant>Vaxfectin</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>3 immunizations 3 weeks apart, with 25 micrograms plasmid in each hindleg.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A 2:1 DNA:adjuvant molar ratio was used. The plasmid expressed human tissue plasminogen..</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenReferenceName>PstS-3 331-350</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>KAFLQSTIGAGQSGLGDNGY</LinearSequence>
                                        <StartingPosition>331</StartingPosition>
                                        <EndingPosition>350</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>CAA88138.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>652616</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>H-2b and H-2p bearing congenic mice produced similar results.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>PstS-3 341-360</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>GQSGLGDNGYIPIPDEFKSR</LinearSequence>
                        <StartingPosition>341</StartingPosition>
                        <EndingPosition>360</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>CAA88138.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>652616</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table I</LocationOfData>
                <EpitopeId>21957</EpitopeId>
                <ReferenceStartingPosition>341</ReferenceStartingPosition>
                <ReferenceEndingPosition>360</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>Protein is also known as Phosphate-binding protein 3 precursor, PBP-3 and Ag88.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 7A</LocationOfData>
                        <TCellId>15804</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000273</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>CAA88138.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>652616</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Adjuvant>Vaxfectin</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>3 immunizations 3 weeks apart, with 25 micrograms plasmid in each hindleg.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A 2:1 DNA:adjuvant molar ratio was used. The plasmid expressed human tissue plasminogen..</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenReferenceName>PstS-3 341-360</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>GQSGLGDNGYIPIPDEFKSR</LinearSequence>
                                        <StartingPosition>341</StartingPosition>
                                        <EndingPosition>360</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>CAA88138.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>652616</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>H-2f and H-2b bearing congenic mice produced similar results.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 1B</LocationOfData>
                        <TCellId>14480</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000047</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>CAA88138.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>652616</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Adjuvant>Vaxfectin</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>3 immunizations 3 weeks apart, with 25 micrograms plasmid in each hindleg.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A 2:1 DNA:adjuvant molar ratio was used. The plasmid expressed human tissue plasminogen..</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenReferenceName>PstS-3 341-360</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>GQSGLGDNGYIPIPDEFKSR</LinearSequence>
                                        <StartingPosition>341</StartingPosition>
                                        <EndingPosition>360</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>CAA88138.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>652616</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>Negative results were also  seen for IL-2 secretion, implying that a Th1 secretion profile is not induced with this peptide. Similar results were seen in H-2f and H-2p bearing congenic mice.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 7B</LocationOfData>
                        <TCellId>15805</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000271</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>CAA88138.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>652616</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Adjuvant>Vaxfectin</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>3 immunizations 3 weeks apart, with 25 micrograms plasmid in each hindleg.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A 2:1 DNA:adjuvant molar ratio was used. The plasmid expressed human tissue plasminogen..</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenReferenceName>PstS-3 341-360</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>GQSGLGDNGYIPIPDEFKSR</LinearSequence>
                                        <StartingPosition>341</StartingPosition>
                                        <EndingPosition>360</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>CAA88138.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>652616</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>H-2b and H-2p bearing congenic mice produced similar results.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>PstS-3 351-369</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>IPIPDEFKSRLSTAVNAIA</LinearSequence>
                        <StartingPosition>351</StartingPosition>
                        <EndingPosition>369</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>CAA88138.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>652616</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table I</LocationOfData>
                <EpitopeId>27875</EpitopeId>
                <ReferenceStartingPosition>351</ReferenceStartingPosition>
                <ReferenceEndingPosition>369</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>Protein is also known as Phosphate-binding protein 3 precursor, PBP-3 and Ag88.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 1B</LocationOfData>
                        <TCellId>14481</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000047</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>CAA88138.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>652616</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Adjuvant>Vaxfectin</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>3 immunizations 3 weeks apart, with 25 micrograms plasmid in each hindleg.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A 2:1 DNA:adjuvant molar ratio was used. The plasmid expressed human tissue plasminogen..</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenReferenceName>PstS-3 351-369</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>IPIPDEFKSRLSTAVNAIA</LinearSequence>
                                        <StartingPosition>351</StartingPosition>
                                        <EndingPosition>369</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>CAA88138.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>652616</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>Negative results were also  seen for IL-2 secretion, implying that a Th1 secretion profile is not induced with this peptide. Similar results were seen in H-2f and H-2p bearing congenic mice.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 7A</LocationOfData>
                        <TCellId>15806</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000273</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>CAA88138.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>652616</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Adjuvant>Vaxfectin</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>3 immunizations 3 weeks apart, with 25 micrograms plasmid in each hindleg.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A 2:1 DNA:adjuvant molar ratio was used. The plasmid expressed human tissue plasminogen..</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenReferenceName>PstS-3 351-369</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>IPIPDEFKSRLSTAVNAIA</LinearSequence>
                                        <StartingPosition>351</StartingPosition>
                                        <EndingPosition>369</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>CAA88138.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>652616</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>H-2f and H-2b bearing congenic mice produced similar results.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 7B</LocationOfData>
                        <TCellId>15807</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000271</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>CAA88138.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>652616</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Adjuvant>Vaxfectin</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>3 immunizations 3 weeks apart, with 25 micrograms plasmid in each hindleg.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A 2:1 DNA:adjuvant molar ratio was used. The plasmid expressed human tissue plasminogen..</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenReferenceName>PstS-3 351-369</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>IPIPDEFKSRLSTAVNAIA</LinearSequence>
                                        <StartingPosition>351</StartingPosition>
                                        <EndingPosition>369</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>CAA88138.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>652616</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>H-2b and H-2p bearing congenic mice produced similar results.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>PstS-3 131-150</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>PIAVTYNLNSVSSLNLDGPT</LinearSequence>
                        <StartingPosition>131</StartingPosition>
                        <EndingPosition>150</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>CAA88138.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>652616</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table I</LocationOfData>
                <EpitopeId>47870</EpitopeId>
                <ReferenceStartingPosition>131</ReferenceStartingPosition>
                <ReferenceEndingPosition>150</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>Protein is also known as Phosphate-binding protein 3 precursor, PBP-3 and Ag88.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 7A</LocationOfData>
                        <TCellId>15808</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000273</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>CAA88138.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>652616</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Adjuvant>Vaxfectin</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>3 immunizations 3 weeks apart, with 25 micrograms plasmid in each hindleg.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A 2:1 DNA:adjuvant molar ratio was used. The plasmid expressed human tissue plasminogen..</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenReferenceName>PstS-3 131-150</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>PIAVTYNLNSVSSLNLDGPT</LinearSequence>
                                        <StartingPosition>131</StartingPosition>
                                        <EndingPosition>150</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>CAA88138.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>652616</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>H-2f and H-2b bearing congenic mice produced similar results.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 7B</LocationOfData>
                        <TCellId>15809</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000271</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>CAA88138.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>652616</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Adjuvant>Vaxfectin</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>3 immunizations 3 weeks apart, with 25 micrograms plasmid in each hindleg.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A 2:1 DNA:adjuvant molar ratio was used. The plasmid expressed human tissue plasminogen..</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenReferenceName>PstS-3 131-150</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>PIAVTYNLNSVSSLNLDGPT</LinearSequence>
                                        <StartingPosition>131</StartingPosition>
                                        <EndingPosition>150</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>CAA88138.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>652616</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>H-2b and H-2p bearing congenic mice produced similar results.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 1B</LocationOfData>
                        <TCellId>14483</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000047</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>CAA88138.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>652616</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Adjuvant>Vaxfectin</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>3 immunizations 3 weeks apart, with 25 micrograms plasmid in each hindleg.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A 2:1 DNA:adjuvant molar ratio was used. The plasmid expressed human tissue plasminogen..</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>181</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>PstS-3 131-150</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>PIAVTYNLNSVSSLNLDGPT</LinearSequence>
                                        <StartingPosition>131</StartingPosition>
                                        <EndingPosition>150</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>CAA88138.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>652616</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Low, albeit significant levels of IFN-g are produced following peptide stimulation, while high levels are seen for IL-2 secretion, implying that a Th1 secretion profile is induced with this peptide. This effect is not affected in K&lt;sup&gt;b&lt;/sup&gt; and D&lt;sup&gt;b&lt;/sup&gt; mutant B6 mice. IFN-g and IL-2 secretion is abolished in I-A&lt;sup&gt;b&lt;/sup&gt;; mutant B6 mice implying a MHC-II I-A restriction in this strain.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>PstS-3 191-210</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>GTTDNFQRYLQAASNGAWGK</LinearSequence>
                        <StartingPosition>191</StartingPosition>
                        <EndingPosition>210</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>CAA88138.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>652616</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table I</LocationOfData>
                <EpitopeId>22851</EpitopeId>
                <ReferenceStartingPosition>191</ReferenceStartingPosition>
                <ReferenceEndingPosition>210</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>Protein is also known as Phosphate-binding protein 3 precursor, PBP-3 and Ag88.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 7B</LocationOfData>
                        <TCellId>15811</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000271</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>CAA88138.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>652616</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Adjuvant>Vaxfectin</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>3 immunizations 3 weeks apart, with 25 micrograms plasmid in each hindleg.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A 2:1 DNA:adjuvant molar ratio was used. The plasmid expressed human tissue plasminogen..</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenReferenceName>PstS-3 191-210</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>GTTDNFQRYLQAASNGAWGK</LinearSequence>
                                        <StartingPosition>191</StartingPosition>
                                        <EndingPosition>210</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>CAA88138.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>652616</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>No IFN-g or IL-2 secretion are seen following peptide stimulation of H-2f bearing mice, implying a Th1 secretion profile is not induced with this peptide in this MHC context.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 1B</LocationOfData>
                        <TCellId>14488</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000047</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>CAA88138.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>652616</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Adjuvant>Vaxfectin</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>3 immunizations 3 weeks apart, with 25 micrograms plasmid in each hindleg.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A 2:1 DNA:adjuvant molar ratio was used. The plasmid expressed human tissue plasminogen..</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>181</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>PstS-3 191-210</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>GTTDNFQRYLQAASNGAWGK</LinearSequence>
                                        <StartingPosition>191</StartingPosition>
                                        <EndingPosition>210</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>CAA88138.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>652616</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>High levels of IFN-g and IL-2 are produced following peptide stimulation, implying a Th1 secretion profile is induced with this peptide. This effect is not affected in k&lt;sup&gt;b&lt;/sup&gt; and D&lt;sup&gt;b&lt;/sup&gt; mutant B6 mice, but cytokine secretion is abolished in I-A&lt;sup&gt;b&lt;/sup&gt; mutant B6 mice, implying a MHC-II I-A restriction.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 7A</LocationOfData>
                        <TCellId>14490</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000273</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>CAA88138.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>652616</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Adjuvant>Vaxfectin</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>3 immunizations 3 weeks apart, with 25 micrograms plasmid in each hindleg.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A 2:1 DNA:adjuvant molar ratio was used. The plasmid expressed human tissue plasminogen..</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenReferenceName>PstS-3 191-210</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>GTTDNFQRYLQAASNGAWGK</LinearSequence>
                                        <StartingPosition>191</StartingPosition>
                                        <EndingPosition>210</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>CAA88138.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>652616</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>No IFN-g or IL-2 secretion are seen following peptide stimulation of H-2p bearing mice, implying a Th1 secretion profile is not induced with the peptide in this MHC context.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>PstS-3 61-80</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>NAMTRFVNVFEQACPGQTLN</LinearSequence>
                        <StartingPosition>61</StartingPosition>
                        <EndingPosition>80</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>CAA88138.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>652616</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table I</LocationOfData>
                <EpitopeId>43221</EpitopeId>
                <ReferenceStartingPosition>61</ReferenceStartingPosition>
                <ReferenceEndingPosition>80</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>Protein is also known as Phosphate-binding protein 3 precursor, PBP-3 and Ag88.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 7A</LocationOfData>
                        <TCellId>14496</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000273</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>CAA88138.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>652616</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Adjuvant>Vaxfectin</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>3 immunizations 3 weeks apart, with 25 micrograms plasmid in each hindleg.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A 2:1 DNA:adjuvant molar ratio was used. The plasmid expressed human tissue plasminogen..</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenReferenceName>PstS-3 61-80</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>NAMTRFVNVFEQACPGQTLN</LinearSequence>
                                        <StartingPosition>61</StartingPosition>
                                        <EndingPosition>80</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>CAA88138.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>652616</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>IFN-g and IL-2 secretion is seen in H-2p bearing mice, implying a Th1 secretion profile is induced with the peptide in this MHC context.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 7B</LocationOfData>
                        <TCellId>15813</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000271</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>CAA88138.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>652616</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Adjuvant>Vaxfectin</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>3 immunizations 3 weeks apart, with 25 micrograms plasmid in each hindleg.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A 2:1 DNA:adjuvant molar ratio was used. The plasmid expressed human tissue plasminogen..</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenReferenceName>PstS-3 61-80</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>NAMTRFVNVFEQACPGQTLN</LinearSequence>
                                        <StartingPosition>61</StartingPosition>
                                        <EndingPosition>80</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>CAA88138.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>652616</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>No IFN-g nor IL-2 secretion is seen in H-2f bearing mice, implying a Th1 secretion profile is not induced with the peptide in this MHC context.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 1B</LocationOfData>
                        <TCellId>14495</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000047</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>CAA88138.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>652616</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Adjuvant>Vaxfectin</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>3 immunizations 3 weeks apart, with 25 micrograms plasmid in each hindleg.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A 2:1 DNA:adjuvant molar ratio was used. The plasmid expressed human tissue plasminogen..</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenReferenceName>PstS-3 61-80</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>NAMTRFVNVFEQACPGQTLN</LinearSequence>
                                        <StartingPosition>61</StartingPosition>
                                        <EndingPosition>80</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>CAA88138.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>652616</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Low, albeit significant levels of IFN-g are produced following peptide stimulation, while no IL-2 secretion was seen, implying a Th1 secretion profile is induced with this peptide. This effect was the same in k&lt;sup&gt;b&lt;/sup&gt;, D&lt;sup&gt;b&lt;/sup&gt; and I-A&lt;sup&gt;b&lt;/sup&gt; mutant B6 mice.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>PstS-3 151-170</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>LAKIFNGSITQWNNPAIQAL</LinearSequence>
                        <StartingPosition>151</StartingPosition>
                        <EndingPosition>170</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>CAA88138.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>652616</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table I</LocationOfData>
                <EpitopeId>34831</EpitopeId>
                <ReferenceStartingPosition>151</ReferenceStartingPosition>
                <ReferenceEndingPosition>170</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>Protein is also known as Phosphate-binding protein 3 precursor, PBP-3 and Ag88.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 1B</LocationOfData>
                        <TCellId>15815</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000047</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>CAA88138.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>652616</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Adjuvant>Vaxfectin</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>3 immunizations 3 weeks apart, with 25 micrograms plasmid in each hindleg.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A 2:1 DNA:adjuvant molar ratio was used. The plasmid expressed human tissue plasminogen..</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenReferenceName>PstS-3 151-170</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>LAKIFNGSITQWNNPAIQAL</LinearSequence>
                                        <StartingPosition>151</StartingPosition>
                                        <EndingPosition>170</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>CAA88138.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>652616</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>High levels of IFN-g and IL-2 are produced following peptide stimulation, implying a Th1 secretion profile is induced with this peptide. This effect is not affected in k&lt;sup&gt;b&lt;/sup&gt;, D&lt;sup&gt;b&lt;/sup&gt; and I-A&lt;sup&gt;b&lt;/sup&gt; mutant B6 mice.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 7A</LocationOfData>
                        <TCellId>15816</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000273</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>CAA88138.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>652616</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Adjuvant>Vaxfectin</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>3 immunizations 3 weeks apart, with 25 micrograms plasmid in each hindleg.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A 2:1 DNA:adjuvant molar ratio was used. The plasmid expressed human tissue plasminogen..</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenReferenceName>PstS-3 151-170</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>LAKIFNGSITQWNNPAIQAL</LinearSequence>
                                        <StartingPosition>151</StartingPosition>
                                        <EndingPosition>170</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>CAA88138.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>652616</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>No IFN-g nor IL-2 secretion is seen in H-2p bearing mice, implying a Th1 secretion profile is not induced with this peptide.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 7B</LocationOfData>
                        <TCellId>15817</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000271</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>CAA88138.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>652616</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Adjuvant>Vaxfectin</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>3 immunizations 3 weeks apart, with 25 micrograms plasmid in each hindleg.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A 2:1 DNA:adjuvant molar ratio was used. The plasmid expressed human tissue plasminogen..</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenReferenceName>PstS-3 151-170</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>LAKIFNGSITQWNNPAIQAL</LinearSequence>
                                        <StartingPosition>151</StartingPosition>
                                        <EndingPosition>170</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>CAA88138.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>652616</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>No IFN-g nor IL-2 secretion is seen in H-2f  bearing mice, implying a Th1 secretion profile is not induced with this peptide.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>PstS-3 161-180</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>QWNNPAIQALNRDFTLPGER</LinearSequence>
                        <StartingPosition>161</StartingPosition>
                        <EndingPosition>180</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>CAA88138.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>652616</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table I</LocationOfData>
                <EpitopeId>52853</EpitopeId>
                <ReferenceStartingPosition>161</ReferenceStartingPosition>
                <ReferenceEndingPosition>180</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>Protein is also known as Phosphate-binding protein 3 precursor, PBP-3 and Ag88.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 7B</LocationOfData>
                        <TCellId>15902</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000271</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>CAA88138.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>652616</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Adjuvant>Vaxfectin</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>3 immunizations 3 weeks apart, with 25 micrograms plasmid in each hindleg.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A 2:1 DNA:adjuvant molar ratio was used. The plasmid expressed human tissue plasminogen..</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenReferenceName>PstS-3 161-180</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>QWNNPAIQALNRDFTLPGER</LinearSequence>
                                        <StartingPosition>161</StartingPosition>
                                        <EndingPosition>180</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>CAA88138.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>652616</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>No IFN-g nor IL-2 secretion is seen in H-2f bearing mice, implying a Th1 secretion profile is not induced with this peptide in this MHC context.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 1B</LocationOfData>
                        <TCellId>15818</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000047</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>CAA88138.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>652616</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Adjuvant>Vaxfectin</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>3 immunizations 3 weeks apart, with 25 micrograms plasmid in each hindleg.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A 2:1 DNA:adjuvant molar ratio was used. The plasmid expressed human tissue plasminogen..</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenReferenceName>PstS-3 161-180</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>QWNNPAIQALNRDFTLPGER</LinearSequence>
                                        <StartingPosition>161</StartingPosition>
                                        <EndingPosition>180</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>CAA88138.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>652616</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>High levels of IFN-g and IL-2 are produced following peptide stimulation, implying a Th1 secretion profile is induced with this peptide. Similar results were seen in H-2p bearing congenic mice.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 7A</LocationOfData>
                        <TCellId>15901</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000273</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>CAA88138.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>652616</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Adjuvant>Vaxfectin</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>3 immunizations 3 weeks apart, with 25 micrograms plasmid in each hindleg.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A 2:1 DNA:adjuvant molar ratio was used. The plasmid expressed human tissue plasminogen..</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenReferenceName>PstS-3 161-180</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>QWNNPAIQALNRDFTLPGER</LinearSequence>
                                        <StartingPosition>161</StartingPosition>
                                        <EndingPosition>180</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>CAA88138.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>652616</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>IFN-g and IL-2 secretion is seen in H-2p bearing mice, implying a Th1 secretion profile is induced with this peptide in this MHC context.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>PstS-3 181-200</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>IHVVFRSDESGTTDNFQRYL</LinearSequence>
                        <StartingPosition>181</StartingPosition>
                        <EndingPosition>200</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>CAA88138.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>652616</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table I</LocationOfData>
                <EpitopeId>26421</EpitopeId>
                <ReferenceStartingPosition>181</ReferenceStartingPosition>
                <ReferenceEndingPosition>200</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>Protein is also known as Phosphate-binding protein 3 precursor, PBP-3 and Ag88.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 7B</LocationOfData>
                        <TCellId>15919</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000271</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>CAA88138.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>652616</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Adjuvant>Vaxfectin</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>3 immunizations 3 weeks apart, with 25 micrograms plasmid in each hindleg.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A 2:1 DNA:adjuvant molar ratio was used. The plasmid expressed human tissue plasminogen..</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenReferenceName>PstS-3 181-200</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>IHVVFRSDESGTTDNFQRYL</LinearSequence>
                                        <StartingPosition>181</StartingPosition>
                                        <EndingPosition>200</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>CAA88138.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>652616</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>No IFN-g nor IL-2 secretion is seen in H-2f bearing mice, implying a Th1 secretion profile is not induced with this peptide.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 7A</LocationOfData>
                        <TCellId>15821</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000273</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>CAA88138.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>652616</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Adjuvant>Vaxfectin</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>3 immunizations 3 weeks apart, with 25 micrograms plasmid in each hindleg.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A 2:1 DNA:adjuvant molar ratio was used. The plasmid expressed human tissue plasminogen..</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenReferenceName>PstS-3 181-200</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>IHVVFRSDESGTTDNFQRYL</LinearSequence>
                                        <StartingPosition>181</StartingPosition>
                                        <EndingPosition>200</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>CAA88138.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>652616</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>No IFN-g nor IL-2 secretion is seen in H-2p bearing mice, implying a Th1 secretion profile is not induced with this peptide.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 1</LocationOfData>
                        <TCellId>15820</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000047</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>CAA88138.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>652616</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Adjuvant>Vaxfectin</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>3 immunizations 3 weeks apart, with 25 micrograms plasmid in each hindleg.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A 2:1 DNA:adjuvant molar ratio was used. The plasmid expressed human tissue plasminogen..</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenReferenceName>PstS-3 181-200</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>IHVVFRSDESGTTDNFQRYL</LinearSequence>
                                        <StartingPosition>181</StartingPosition>
                                        <EndingPosition>200</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>CAA88138.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>652616</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Low, albeit significant levels of IFN-g are produced following peptide stimulation, while high levels of IL-2 secretion are induced, implying a Th1 secretion profile is induced with this peptide.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>PstS-3 201-220</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>QAASNGAWGKGAGKSFQGGV</LinearSequence>
                        <StartingPosition>201</StartingPosition>
                        <EndingPosition>220</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>CAA88138.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>652616</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table I</LocationOfData>
                <EpitopeId>50219</EpitopeId>
                <ReferenceStartingPosition>201</ReferenceStartingPosition>
                <ReferenceEndingPosition>220</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>Protein is also known as Phosphate-binding protein 3 precursor, PBP-3 and Ag88.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 7A</LocationOfData>
                        <TCellId>15823</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000273</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>CAA88138.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>652616</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Adjuvant>Vaxfectin</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>3 immunizations 3 weeks apart, with 25 micrograms plasmid in each hindleg.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A 2:1 DNA:adjuvant molar ratio was used. The plasmid expressed human tissue plasminogen..</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenReferenceName>PstS-3 201-220</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>QAASNGAWGKGAGKSFQGGV</LinearSequence>
                                        <StartingPosition>201</StartingPosition>
                                        <EndingPosition>220</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>CAA88138.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>652616</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>No IFN-g nor IL-2 secretion is seen in H-2p bearing mice, implying a Th1 secretion profile is not induced with the peptide in this MHC context.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 7B</LocationOfData>
                        <TCellId>15921</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000271</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>CAA88138.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>652616</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Adjuvant>Vaxfectin</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>3 immunizations 3 weeks apart, with 25 micrograms plasmid in each hindleg.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A 2:1 DNA:adjuvant molar ratio was used. The plasmid expressed human tissue plasminogen..</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenReferenceName>PstS-3 201-220</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>QAASNGAWGKGAGKSFQGGV</LinearSequence>
                                        <StartingPosition>201</StartingPosition>
                                        <EndingPosition>220</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>CAA88138.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>652616</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Low but significant IFN-g and IL-2 secretion is seen in H-2f bearing mice, implying a Th1 secretion profile is induced with this peptide in this MHC context.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 1</LocationOfData>
                        <TCellId>15822</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000047</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>CAA88138.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>652616</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Adjuvant>Vaxfectin</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>3 immunizations 3 weeks apart, with 25 micrograms plasmid in each hindleg.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A 2:1 DNA:adjuvant molar ratio was used. The plasmid expressed human tissue plasminogen..</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenReferenceName>PstS-3 201-220</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>QAASNGAWGKGAGKSFQGGV</LinearSequence>
                                        <StartingPosition>201</StartingPosition>
                                        <EndingPosition>220</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>CAA88138.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>652616</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Low levels of IFN-g are produced following peptide stimulation, while high levels of IL-2 secretion are induced, implying a Th1 secretion profile is induced with this peptide. Similar results were seen in H-2f bearing congenic mice.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>PstS-3 261-280</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>TSAGGDPVAITIDSVGQTIA</LinearSequence>
                        <StartingPosition>261</StartingPosition>
                        <EndingPosition>280</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>CAA88138.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>652616</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table I</LocationOfData>
                <EpitopeId>66151</EpitopeId>
                <ReferenceStartingPosition>261</ReferenceStartingPosition>
                <ReferenceEndingPosition>280</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>Protein is also known as Phosphate-binding protein 3 precursor, PBP-3 and Ag88.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 7B</LocationOfData>
                        <TCellId>15906</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000271</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>CAA88138.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>652616</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Adjuvant>Vaxfectin</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>3 immunizations 3 weeks apart, with 25 micrograms plasmid in each hindleg.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A 2:1 DNA:adjuvant molar ratio was used. The plasmid expressed human tissue plasminogen..</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenReferenceName>PstS-3 261-280</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>TSAGGDPVAITIDSVGQTIA</LinearSequence>
                                        <StartingPosition>261</StartingPosition>
                                        <EndingPosition>280</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>CAA88138.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>652616</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>High levels of IFN-g and  IL-2 secretion is seen in H-2f bearing mice, implying a Th1 secretion profile is induced with this peptide.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 1</LocationOfData>
                        <TCellId>15824</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000047</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>CAA88138.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>652616</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Adjuvant>Vaxfectin</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>3 immunizations 3 weeks apart, with 25 micrograms plasmid in each hindleg.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A 2:1 DNA:adjuvant molar ratio was used. The plasmid expressed human tissue plasminogen..</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenReferenceName>PstS-3 261-280</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>TSAGGDPVAITIDSVGQTIA</LinearSequence>
                                        <StartingPosition>261</StartingPosition>
                                        <EndingPosition>280</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>CAA88138.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>652616</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Low levels of IFN-g are produced following peptide stimulation, but only borderline levels of IL-2, implying a Th1 secretion profile is not induced with this peptide.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 7A</LocationOfData>
                        <TCellId>15825</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000273</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>CAA88138.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>652616</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Adjuvant>Vaxfectin</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>3 immunizations 3 weeks apart, with 25 micrograms plasmid in each hindleg.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A 2:1 DNA:adjuvant molar ratio was used. The plasmid expressed human tissue plasminogen..</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenReferenceName>PstS-3 261-280</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>TSAGGDPVAITIDSVGQTIA</LinearSequence>
                                        <StartingPosition>261</StartingPosition>
                                        <EndingPosition>280</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>CAA88138.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>652616</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>No IFN-g nor IL-2 secretion is seen in H-2p bearing mice, implying a Th1 secretion profile is not induced with this peptide.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>PstS-3 271-290</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>TIDSVGQTIAGATISGVGND</LinearSequence>
                        <StartingPosition>271</StartingPosition>
                        <EndingPosition>290</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>CAA88138.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>652616</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table I</LocationOfData>
                <EpitopeId>64277</EpitopeId>
                <ReferenceStartingPosition>271</ReferenceStartingPosition>
                <ReferenceEndingPosition>290</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>Protein is also known as Phosphate-binding protein 3 precursor, PBP-3 and Ag88.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 1</LocationOfData>
                        <TCellId>15826</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000047</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>CAA88138.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>652616</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Adjuvant>Vaxfectin</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>3 immunizations 3 weeks apart, with 25 micrograms plasmid in each hindleg.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A 2:1 DNA:adjuvant molar ratio was used. The plasmid expressed human tissue plasminogen..</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenReferenceName>PstS-3 271-290</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>TIDSVGQTIAGATISGVGND</LinearSequence>
                                        <StartingPosition>271</StartingPosition>
                                        <EndingPosition>290</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>CAA88138.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>652616</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Low levels of IFN-g are produced following peptide stimulation, but only borderline levels of IL-2, implying a Th1 secretion profile is not induced with this peptide.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 7A</LocationOfData>
                        <TCellId>15827</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000273</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>CAA88138.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>652616</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Adjuvant>Vaxfectin</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>3 immunizations 3 weeks apart, with 25 micrograms plasmid in each hindleg.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A 2:1 DNA:adjuvant molar ratio was used. The plasmid expressed human tissue plasminogen..</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenReferenceName>PstS-3 271-290</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>TIDSVGQTIAGATISGVGND</LinearSequence>
                                        <StartingPosition>271</StartingPosition>
                                        <EndingPosition>290</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>CAA88138.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>652616</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>IFN-g and  IL-2 secretion is seen in H-2p bearing mice, implying a Th1 secretion profile is induced with this peptide.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 7B</LocationOfData>
                        <TCellId>15922</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000271</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>CAA88138.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>652616</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Adjuvant>Vaxfectin</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>3 immunizations 3 weeks apart, with 25 micrograms plasmid in each hindleg.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A 2:1 DNA:adjuvant molar ratio was used. The plasmid expressed human tissue plasminogen..</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenReferenceName>PstS-3 271-290</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>TIDSVGQTIAGATISGVGND</LinearSequence>
                                        <StartingPosition>271</StartingPosition>
                                        <EndingPosition>290</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>CAA88138.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>652616</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>IFN-g and  IL-2 secretion is seen in H-2f bearing mice, implying a Th1 secretion profile is induced with this peptide.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>PstS-3 291-310</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>LVLDTDSFYRPKRPGSYPIV</LinearSequence>
                        <StartingPosition>291</StartingPosition>
                        <EndingPosition>310</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>CAA88138.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>652616</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table I</LocationOfData>
                <EpitopeId>40438</EpitopeId>
                <ReferenceStartingPosition>291</ReferenceStartingPosition>
                <ReferenceEndingPosition>310</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>Protein is also known as Phosphate-binding protein 3 precursor, PBP-3 and Ag88.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 7A</LocationOfData>
                        <TCellId>15903</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000273</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>CAA88138.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>652616</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Adjuvant>Vaxfectin</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>3 immunizations 3 weeks apart, with 25 micrograms plasmid in each hindleg.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A 2:1 DNA:adjuvant molar ratio was used. The plasmid expressed human tissue plasminogen..</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenReferenceName>PstS-3 291-310</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>LVLDTDSFYRPKRPGSYPIV</LinearSequence>
                                        <StartingPosition>291</StartingPosition>
                                        <EndingPosition>310</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>CAA88138.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>652616</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Low levels of IFN-g are produced following peptide stimulation in H-2p bearing mice.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 1</LocationOfData>
                        <TCellId>15828</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000047</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>CAA88138.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>652616</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Adjuvant>Vaxfectin</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>3 immunizations 3 weeks apart, with 25 micrograms plasmid in each hindleg.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A 2:1 DNA:adjuvant molar ratio was used. The plasmid expressed human tissue plasminogen..</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenReferenceName>PstS-3 291-310</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>LVLDTDSFYRPKRPGSYPIV</LinearSequence>
                                        <StartingPosition>291</StartingPosition>
                                        <EndingPosition>310</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>CAA88138.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>652616</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Low levels of IFN-g are produced following peptide stimulation, but only borderline levels of IL-2, implying a Th1 secretion profile is not induced with this peptide.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 7B</LocationOfData>
                        <TCellId>15904</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000271</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>CAA88138.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>652616</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Adjuvant>Vaxfectin</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>3 immunizations 3 weeks apart, with 25 micrograms plasmid in each hindleg.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A 2:1 DNA:adjuvant molar ratio was used. The plasmid expressed human tissue plasminogen..</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenReferenceName>PstS-3 291-310</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>LVLDTDSFYRPKRPGSYPIV</LinearSequence>
                                        <StartingPosition>291</StartingPosition>
                                        <EndingPosition>310</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>CAA88138.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>652616</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Low levels of IFN-g are produced following peptide stimulation in H-2f bearing mice.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>PstS-3 285-293</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>SGVGNDLVL</LinearSequence>
                        <StartingPosition>285</StartingPosition>
                        <EndingPosition>293</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>CAA88138.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>652616</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table I</LocationOfData>
                <EpitopeId>58286</EpitopeId>
                <ReferenceStartingPosition>285</ReferenceStartingPosition>
                <ReferenceEndingPosition>293</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>Protein is also known as Phosphate-binding protein 3 precursor, PBP-3 and Ag88.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 3A</LocationOfData>
                        <TCellId>15830</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000067</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>CAA88138.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>652616</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Adjuvant>Vaxfectin</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>3 immunizations 3 weeks apart, with 25 micrograms plasmid in each hindleg.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A 2:1 DNA:adjuvant molar ratio was used. The plasmid expressed human tissue plasminogen..</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>172</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>PstS-3 285-293</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>SGVGNDLVL</LinearSequence>
                                        <StartingPosition>285</StartingPosition>
                                        <EndingPosition>293</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>CAA88138.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>652616</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>48</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>High numbers of INF-g secreting splenocytes are produced in source protein-encoding DNA vaccinated mice and in source species infected mice in response to epitope stimulation. This effect is not seen in 2M-/- mice, lacking functional CD8+ cells. Similar results were obtained by tetramer staining of CD8+ lymphocytes.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 5</LocationOfData>
                        <TCellId>15831</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000067</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>CAA88138.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>652616</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Adjuvant>Vaxfectin</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>3 immunizations 3 weeks apart, with 25 micrograms plasmid in each hindleg.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A 2:1 DNA:adjuvant molar ratio was used. The plasmid expressed human tissue plasminogen..</ImmunizationComments>
                        </Immunization>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>172</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>PstS-3 285-293</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>SGVGNDLVL</LinearSequence>
                                        <StartingPosition>285</StartingPosition>
                                        <EndingPosition>293</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>CAA88138.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>652616</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>246</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Specific lysis of peptide pulsed APCs is seen in vivo in source protein-expressing DNA vaccinated, as well as in source species infected mice.  Peptide pulsed nave splenocytes labeled with high concentration of CSFE were injected in DNA vaccinated or Mtb infected animals, and lysis was determined as the reduction in the CSFE high signal, in comparison to the signal obtained from control non pulsed, CSFE low splenocytes injected at the same time in a 1:1 ratio.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 1</LocationOfData>
                        <TCellId>15829</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000047</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>CAA88138.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>652616</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Adjuvant>Vaxfectin</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>3 immunizations 3 weeks apart, with 25 micrograms plasmid in each hindleg.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A 2:1 DNA:adjuvant molar ratio was used. The plasmid expressed human tissue plasminogen..</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>172</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>PstS-3 281-300</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Fragment of Source Antigen</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>GATISGVGNDLVLDTDSFYR</LinearSequence>
                                        <StartingPosition>281</StartingPosition>
                                        <EndingPosition>300</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>CAA88138.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>652616</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>High levels of IFN-g are produced following peptide stimulation, while IL-2 release is negative, implying a CD8+ response is induced with this peptide. Similar results were seen in H-2p bearing congenic mice. CD8+ lymphocytes from B6 mice produce IFN-g upon peptide stimulation and the response was abolished in D&lt;sup&gt;b&lt;/sup&gt; mutant B6 mice, confirming the induction of a Db restricted CD8+ response responsible for IFN-g secretion.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 7A</LocationOfData>
                        <TCellId>15925</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000273</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>CAA88138.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>652616</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Adjuvant>Vaxfectin</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>3 immunizations 3 weeks apart, with 25 micrograms plasmid in each hindleg.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A 2:1 DNA:adjuvant molar ratio was used. The plasmid expressed human tissue plasminogen..</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>172</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>PstS-3 281-300</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Fragment of Source Antigen</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>GATISGVGNDLVLDTDSFYR</LinearSequence>
                                        <StartingPosition>281</StartingPosition>
                                        <EndingPosition>300</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>CAA88138.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>652616</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>High levels of IFN-g are produced following peptide stimulation, while IL-2 release was negative, implying that a CD8+ reponse is induced with this peptide. A similar secretion profile was seen in H-2b bearing mice and was proven to be a CD8+ Db-restricted response.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 7B</LocationOfData>
                        <TCellId>15926</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000271</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-10 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>CAA88138.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>652616</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Adjuvant>Vaxfectin</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>3 immunizations 3 weeks apart, with 25 micrograms plasmid in each hindleg.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A 2:1 DNA:adjuvant molar ratio was used. The plasmid expressed human tissue plasminogen..</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>172</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>PstS-3 281-300</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Fragment of Source Antigen</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>GATISGVGNDLVLDTDSFYR</LinearSequence>
                                        <StartingPosition>281</StartingPosition>
                                        <EndingPosition>300</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>CAA88138.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>652616</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>Low levels of IFN-g are produced following peptide stimulation, however, intracellular cytokine staining for IFN-g was negative in CD8+ cells. IL-2 release was also negative, implying that a CD8+ reponse is not induced in this haplotype.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
        </Epitopes>
    </Reference>
</References>

